Journal of Postgraduate Medicine, Education and Research

Register      Login

VOLUME 47 , ISSUE 1 ( January-March, 2013 ) > List of Articles

REVIEW ARTICLE

An Increasing Role for 68Ga PET Imaging: A Perspective on the Availability of Parent 68Ge Material for Generator Manufacturing in an Expanding Market

Michael K Schultz, Patrick Donahue, Nannette I Musgrave, Konstantin Zhernosekov, Clive Naidoo, Anatolii Razbash, Izabella Tworovska, David W Dick, G Leonard Watkins, Michael M Graham, Wolfgang Runde, Jeffrey A Clanton, John J Sunderland

Citation Information : Schultz MK, Donahue P, Musgrave NI, Zhernosekov K, Naidoo C, Razbash A, Tworovska I, Dick DW, Watkins GL, Graham MM, Runde W, Clanton JA, Sunderland JJ. An Increasing Role for 68Ga PET Imaging: A Perspective on the Availability of Parent 68Ge Material for Generator Manufacturing in an Expanding Market. J Postgrad Med Edu Res 2013; 47 (1):26-30.

DOI: 10.5005/jp-journals-10028-1053

Published Online: 00-03-2013

Copyright Statement:  Copyright © 2013; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

How to cite this article

Schultz MK, Donahue P, Musgrave NI, Zhernosekov K, Naidoo C, Razbash A, Tworovska I, Dick DW, Watkins GL, Graham MM, Runde W, Clanton JA, Sunderland JJ. An Increasing Role for 68Ga PET Imaging: A Perspective on the Availability of Parent 68Ge Material for Generator Manufacturing in an Expanding Market. J Postgrad Med Edu Res 2013;47(1):26-30.


PDF Share
  1. Radiolabelling DOTA-peptides with 68Ga. Eur J Nucl Med Mol Imag 2005;32(4):478-85.
  2. Gallium-68-A new opportunity for PET available from a long shelf-life generator-automation and applications. Curr Radiopharm 2012;5(3):212-20.
  3. 68Ga-PET: A powerful generatorbased alternative to cyclotron-based PET radiopharmaceuticals. Contrast Media Mol Imag 2008;3(2):67-77.
  4. Radiopharmaceutical development of radiolabelled peptides. Eur J Nucl Med Mol Imag 2012;39 Suppl 1:11-30.
  5. Gallium-68: A new trend in PET radiopharmacy. Curr Radiopharm 2012;5(2):142-49.
  6. Maturation of a key resource-the germanium-68/gallium-68 generator: Development and new insights. Curr Radiopharm 2012;5(3):202-11.
  7. [68Ga]Gallium-labelled PSMA ligand as superior PET tracer for the diagnosis of prostate cancer: Comparison with 18F-FECH. Eur J Nucl Med Mol Imag 2012 Jun;39(6):1085-86.
  8. Synthesis, radiometal labeling and in vitro evaluation of a targeted PPIX derivative. Appl Radiat Isot 2012;70(3):505-11.
  9. Molecular imaging of HER2-expressing malignant tumors in breast cancer patients using synthetic 111Inor 68Ga-labeled affibody molecules. J Nucl Med 2010;51(6): 892-97.
  10. Automated module radiolabeling of peptides and antibodies with gallium-68, lutetium-177 and iodine-131. Cancer Biother Radiopharm 2012;27(1):72-76.
  11. Prosthetic joint infections: Radionuclide state-of-the-art imaging. Eur J Nucl Med Mol Imag 2012 May; 39(5):892-909.
  12. Radiometallo-labeled peptides in tumor diagnosis and therapy. Met Ions Biol Syst 2004;42:109-42.
  13. PET of CXCR4 expression by a 68Ga-labeled highly specific targeted contrast agent. J Nucl Med 2011;52(11): 1803-10.
  14. 68Ga-labeled peptides in tumor imaging. J Nucl Med 2005;46(Suppl 1):172S-78.
  15. 68Galabeling and in vivo evaluation of a uPAR binding DOTA- and NODAGA-conjugated peptide for PET imaging of invasive cancers. Nucl Med Biol 2012 May;39(4):560-69.
  16. Complexation of metal ions with TRAP (1,4,7-triazacyclononane phosphinic acid) ligands and 1, 4, 7-triazacyclononane-1, 4, 7-triacetic acid: Phosphinate-containing ligands as unique chelators for trivalent gallium. Inorg Chem 2012;51(1):577-90.
  17. Evaluation of 68Ga-labeled tracers for PET imaging of myocardial perfusion in pigs. Nucl Med Biol 2012 Jul;39(5):715-23.
  18. Gallium-labelled peptides for imaging of inflammation. Eur J Nucl Med Mol Imag 2012;39 (Suppl 1):68-77.
  19. Comparison of 68Ga-DOTATOC PET and 111In-DTPAOC (Octreoscan) SPECT in patients with neuroendocrine tumours. Eur J Nucl Med Mol Imag 2007;34(10): 1617-26.
  20. 68Ga-labelled DOTA-derivatised peptide ligands. Eur J Nucl Med Mol Imag 2004;31(8):1097-1104.
  21. Processing of generator-produced 68Ga for medical application. J Nucl Med 2007;48(10):1741-48.
  22. The 68Ge/68Ga generator has high potential, but when can we use 68Ga-labelled tracers in clinical routine? Eur J Nucl Med Mol Imag 2007;34(7):978-81.
  23. Situation of supply and boom of PET imaging: What is the future for technetium-99m in nuclear medicine? Ann Pharm Fr 2011;69(3):155-64.
  24. Technetium-99m supply shortage. Possible solutions in every day nuclear cardiology practice. Quart J Nucl Med Mol Img 2011;55(1): 103-04.
  25. Characteristics of SnO2-based 68Ge/68Ga generator and aspects of radiolabelling DOTA-peptides. Appl Radiat Isot 2011;69(2):308-15.
  26. Development of a nano-zirconia based 68Ge/68Ga generator for biomedical applications. Nucl Med Biol 2011; 38(4):575-83.
  27. 68Ga-autoclabeling of DOTA-TATE and DOTA-NOC. Appl Rad Isot 2012;70(6):980-83.
  28. A new 68Ge/68Ga generator system using an organic polymer containing N-methylglucamine groups as adsorbent for 68Ge. Appl Rad Isot 2003;58(1):9-14.
  29. Molecule for functionalizing a support, attachment of a radionuclide to the support and radionuclide generator for preparing the radionuclide and preparation process. US Patent Application Publication, 2010. US 2010/0202915 A1(August 12, 2010).
  30. A positron cow. Int J Appl Radiat Isot 1960;8: 90-94.
  31. A gallium-68 positron cow for medical use. J Nucl Med 1964;5:484-87.
  32. Production of long lived parent radionuclides for generators: 68Ge, 82Sr, 90Sr and 188W. 2010. STI/PUB/1436.
  33. Science 1945;102(2653):441
  34. Managing critical isotopes: DOE's isotope program needs better planning for setting prices and managing production risks. GAO Report 2012;12-591.
  35. Germanium-68 row of products. 5th International Conference on Isotopes 2005;146-51.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.